Benchmark Capital Advisors’s BioLineRX BLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | $63K | Hold |
238
| – | – | 0.06% | 107 |
|
|
2018
Q3 | $153K | Hold |
238
| – | – | 0.12% | 120 |
|
|
2018
Q2 | $127K | Hold |
238
| – | – | 0.1% | 121 |
|
|
2018
Q1 | $124K | Hold |
238
| – | – | 0.1% | 123 |
|
|
2017
Q4 | $156K | Sell |
238
-5
| -2% | -$3.28K | 0.12% | 123 |
|
|
2017
Q3 | $164K | Buy |
243
+3
| +1% | +$2.03K | 0.13% | 127 |
|
|
2017
Q2 | $122K | Hold |
240
| – | – | 0.1% | 126 |
|
|
2017
Q1 | $138K | Buy |
240
+167
| +229% | +$96K | 0.11% | 108 |
|
|
2016
Q4 | $40K | Hold |
73
| – | – | 0.03% | 120 |
|
|
2016
Q3 | $51K | Hold |
73
| – | – | 0.04% | 125 |
|
|
2016
Q2 | $35K | Sell |
73
-5
| -6% | -$2.4K | 0.03% | 123 |
|
|
2016
Q1 | $48K | Hold |
78
| – | – | 0.04% | 117 |
|
|
2015
Q4 | $61K | Hold |
78
| – | – | 0.05% | 115 |
|
|
2015
Q3 | $72K | Sell |
78
-44
| -36% | -$40.6K | 0.06% | 120 |
|
|
2015
Q2 | $194K | Buy |
122
+55
| +82% | +$87.5K | 0.14% | 115 |
|
|
2015
Q1 | $84K | Hold |
67
| – | – | 0.06% | 121 |
|
|
2014
Q4 | $65K | Hold |
67
| – | – | 0.04% | 118 |
|
|
2014
Q3 | $62K | Hold |
67
| – | – | 0.04% | 117 |
|
|
2014
Q2 | $83K | Buy |
67
+34
| +103% | +$42.1K | 0.05% | 119 |
|
|
2014
Q1 | $45K | Buy |
+33
| New | +$45K | 0.03% | 123 |
|